Year: 2020
10 Simple Ways to Reduce the Risk of Lung Cancer
Though not all lung cancers can be prevented, but there are things that one can do to reduce the risk of lung cancer. Lung cancer is considered as smoker’s [...]
Non-Smoking Lung Cancer Patients May Respond Differently to Treatment
Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers [...]
Ginger May Help Fight Lung Cancer
When one is undergoing lung cancer treatment, the taste diminishes or even changes. The patient goes through a lot of mental, physical as well as psychological [...]
Anti-Cancer Properties of Saffron to help Lung Cancer Patients
Lung cancer is the most common form of cancer worldwide. It is not only difficult to cure but also has a high incidence of recurrence. Thus, the development of [...]
Near-Infrared Light Treatment for A Rare Form Of Lung Cancer
Nagoya University oncologist Kazuhide Sato and team have tested the treatment for a rare type of malignant lung cancer and published its findings in the [...]
Is Cinnamon Beneficial for Lung Cancer Patients?
Cinnamon is one of the oldest known spices and has a naturally sweet flavor. It is obtained from the inner bark of several tree species. It is widely used in [...]
Study: Nicotine May Promote Brain Tumors in Lung Cancer Patients
According to a new study, researchers have found that nicotine actually promotes the spread of lung cancer cells into the brain where they can form deadly [...]
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by [...]
U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Lung Cancer Patients May Face Risk of Death from COVID-19
The continuous fear of COVID-19 is on the rise. With more and more people getting trapped in this pandemic, it also offers risk to those who already have [...]